# Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients

> **NCT01494285** · PHASE1,PHASE2 · COMPLETED · sponsor: **M. Arkin 1999 Ltd.** · enrollment: 157 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** ARK-E021 5%
- **DRUG:** ARK-E021 10%
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01494285
- **Lead sponsor:** M. Arkin 1999 Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2013-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01494285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01494285, "Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01494285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*